SCHEMBL3386126

SCHEMBL3386126

O=C(Nc1ccc(-c2ccc3c(C(=O)O)n[nH]c3c2)cc1)c1cscn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 1/20 0.43
GRM4 Q14833 1/20 0.42
FLT3 P36888 2/20 0.42
CDK2 P24941 2/20 0.42
CCNA2 P20248 1/20 0.42
CCNA1 P78396 1/20 0.42
PRKAG1 P54619 4/20 0.41
PRKAA1 Q13131 4/20 0.41
PRKAB1 Q9Y478 4/20 0.41
FGFR1 P11362 1/20 0.40
FGFR2 P21802 1/20 0.40
FGFR3 P22607 1/20 0.40
JAK2 O60674 1/20 0.40
JAK1 P23458 1/20 0.40
TYK2 P29597 1/20 0.40
JAK3 P52333 1/20 0.40
HDAC6 Q9UBN7 2/20 0.40
PAK1 Q13153 2/20 0.40
AAK1 Q2M2I8 1/20 0.40
GRM1 Q13255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3387655 0.90 PAK1 (0.53) PTGDR2GRM4FLT3CDK2CCNA2
SCHEMBL3386078 0.85 KDM4E (0.46) FLT3FGFR1FGFR2FGFR3JAK2
SCHEMBL3385649 0.83 NPC1 (0.50) WNT1DYRK1A
SCHEMBL3383259 0.79 MAPT (0.57) ITKGSK3B
SCHEMBL3386831 0.79 NPC1 (0.54) FLT3PRKAG1PRKAA1PRKAB1
SCHEMBL3385551 0.77 SGK1 (0.47) FLT3CDK2CCNA2CCNA1PRKAG1
SCHEMBL3386038 0.75 DYRK1A (0.48) FLT3CDK2CCNA2CCNA1PRKAG1
SCHEMBL3380466 0.75 PAK1 (0.47) PRKAG1PRKAA1PRKAB1JAK2JAK1
SCHEMBL3386591 0.75 KDR (0.50) FLT3PRKAG1PRKAA1PRKAB1JAK3
SCHEMBL3384011 0.74 HDAC1 (0.51) PTGDR2FLT3CDK2CCNA2CCNA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010064875-A2 NOVEL INDAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS PROTEIN KINASE INHIBITORS FOR PROLIFERATIVE DISEASES TREATMENT, AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS AN ACTIVE INGREDIENT KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2010-06-10 WO claimed
WO-2010064875-A2 NOVEL INDAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS PROTEIN KINASE INHIBITORS FOR PROLIFERATIVE DISEASES TREATMENT, AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS AN ACTIVE INGREDIENT KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2010-06-10 WO disclosed